Evaluating Pharmaceuticals For Health Policy And Reimbursement
DOWNLOAD
FREE 30 Days
Download Evaluating Pharmaceuticals For Health Policy And Reimbursement PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get Evaluating Pharmaceuticals For Health Policy And Reimbursement book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages. If the content not found or just blank you must refresh this page
Evaluating Pharmaceuticals For Health Policy And Reimbursement
DOWNLOAD
FREE 30 Days
Author : Nick Freemantle
language : en
Publisher: John Wiley & Sons
Release Date : 2008-04-15
Evaluating Pharmaceuticals For Health Policy And Reimbursement written by Nick Freemantle and has been published by John Wiley & Sons this book supported file pdf, txt, epub, kindle and other format this book has been release on 2008-04-15 with Medical categories.
“The challenge in all settings is to make the difficultdecisions in a way that is defensible, justifiable, ethical, andequitable” So write Nick Freemantle and Suzanne Hill in their introductionto this important discussion on decision making in thereimbursement of pharmaceuticals. Based around a programmesupported by the World Health Organization, chapters by leadingacademics involved in the research tackle such major issues asinternational pharmaceutical policy, tensions in licensingpolicies, priority setting, and relationships between thestakeholders. Chapters include Development of marketing authorisation procedures forpharmaceuticals Interpreting clinical evidence International pharmaceutical policy: health creation or wealthcreation? Development of fourth hurdle policies around the world Economic modelling in drug reimbursement Priority setting in health care: matching decision criteriawith policy objectives Tensions in licensing and reimbursement decisions: case ofriluzole for amytrophic lateral sclerosis Relationship between stakeholders: managing the war ofwords Medicine and the media: good information or misleadinghype? How to promote quality use of cost-effective medicines Using economic evaluation to inform health policy andreimbursement: making it happen and making it sustainable Pricing of pharmaceuticals Evaluating pharmaceuticals for health policy in low and middleincome country settings. Besides the controversial issues there is a wealth of practicalinformation including economic modelling and the experiences fromthe WHO programme, providing readers with workable examples. Thisis essential reading for clinical researchers in pharmaceuticalsand policy makers everywhere.
European Medicines Pricing And Reimbursement
DOWNLOAD
FREE 30 Days
Author : Martina Garau
language : en
Publisher: CRC Press
Release Date : 2018-04-19
European Medicines Pricing And Reimbursement written by Martina Garau and has been published by CRC Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2018-04-19 with Medical categories.
This book is published in association with the Office of Health Economics. This book is a vital, non-technical guide illuminating recent developments within the five major European pharmaceutical markets. It clearly explains pharmaceutical regulatory policies on pricing and reimbursement, and their effects. Each chapter gives an overview of the current market, including aims, effectiveness, local markets, frameworks and politics, and then offers predictions for the next decade. Pharmaceutical executives with interests in marketing, market access and pricing will find this guide invaluable, as will health economists, government advisors and public affairs consultants. Public policy makers in areas such as the Department of Health and The Treasury and senior health service managers in hospitals will find it enlightening. It is also highly relevant to policy shapers in academia and the media, and undergraduate and postgraduate students of health economics, health policy, pharmaceutical economics and healthcare management. "This book aims not only to understand and discuss the mix of regulatory measures introduced by national policy makers in order to achieve their goals, but also to ascertain how these policies have actually shaped and influenced the characteristics and functioning of national pharmaceutical markets. In particular, each author has provided an analysis of existing pricing and reimbursement arrangements operating in their own country and an outline of policy scenarios that might emerge in the next decade." - Martina Garau and Jorge Mestre-Ferrandiz, in the Introduction.
Health Policy Developments 13
DOWNLOAD
FREE 30 Days
Author : Ray Moynihan
language : en
Publisher: Verlag Bertelsmann Stiftung
Release Date : 2010-07-30
Health Policy Developments 13 written by Ray Moynihan and has been published by Verlag Bertelsmann Stiftung this book supported file pdf, txt, epub, kindle and other format this book has been release on 2010-07-30 with Health & Fitness categories.
Health policy in times of crisis is one of the topics of Health Policy Developments 13 exploring the challenge the crisis has posed to health systems, but also asking whether it has provided an opportunity for reform. While some countries like Estonia drastically reduced their healthcare budgets, others, such as Austria and the United States, have responded with plans to boost public expenditure. Can the crisis provide a window of opportunity for reform? In spite of the global financial crisis, for many, confidence in market mechanisms seems not to have been shaken. One of the key assumptions of contemporary health policy debate remains: more competition will help produce systems where resources are used more efficiently. However, as governments seek to enhance market mechanisms in health systems, successful regulation is needed to facilitate those changes and avoid unintended consequences. To assess the effects of competition and regulation, as well as other reform approaches, systematic analysis is needed. Health policy evaluation, therefore, is another focus of this issue of Health Policy Developments, as well as hospital care and its coordination with other sectors, prevention and health inequalities. The International Network Health Policy and Reform aims to narrow the gap between health services research and health policy. Network partners are research institutions and health policy experts from 20 industrialized countries.
Pharmaceutical Market Access In Emerging Markets
DOWNLOAD
FREE 30 Days
Author : Güvenç Koçkaya
language : en
Publisher: SEEd
Release Date : 2016-10-20
Pharmaceutical Market Access In Emerging Markets written by Güvenç Koçkaya and has been published by SEEd this book supported file pdf, txt, epub, kindle and other format this book has been release on 2016-10-20 with Business & Economics categories.
The definition of Market Access was first reported by the World Trade Organization as “to open markets for trade and improve transparency, reciprocity, and non-discrimination in international trade”. Pharmaceutical Market Access is different and it could be defined as achieving the optimal price for a product or service and/or the maximum reimbursement for the approved target population with no restrictions on funding for the medical technology. By the way, Market Access is not only the market authorization, but it also includes overlapping activities like pricing, health technology assessment, formulary, and reimbursement. Market Access is one of the most important activities for pharmaceutical companies and emerging countries represent an important opportunity for launching new products. It was reported that the Compounded Average Growth Rate (CAGR) was 6.0% in the period 2011-2017, and expected sales exceeding 1.1 trillion USD by 2017 for emerging countries. Furthermore, CAGR 2008-2012 for recently launched pharmaceuticals were 9.8% for emerging countries and 1.5% for the top 8 developed countries. The Market Access processes in the most important emerging countries in the selected regions are defined in this book with the aim to help local experts, local government officers, headquarter managements, and everyone who want to learn more about healthcare system and health policies pathways of Market Access, mapping and structure of decision makers, challenges and catalyzers for Market Access in the emerging countries.
Making Medicines Affordable
DOWNLOAD
FREE 30 Days
Author : National Academies of Sciences, Engineering, and Medicine
language : en
Publisher: National Academies Press
Release Date : 2018-03-01
Making Medicines Affordable written by National Academies of Sciences, Engineering, and Medicine and has been published by National Academies Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2018-03-01 with Medical categories.
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Who Guideline On Country Pharmaceutical Pricing Policies
DOWNLOAD
FREE 30 Days
Author :
language : en
Publisher: World Health Organization
Release Date : 2020-09-29
Who Guideline On Country Pharmaceutical Pricing Policies written by and has been published by World Health Organization this book supported file pdf, txt, epub, kindle and other format this book has been release on 2020-09-29 with Business & Economics categories.
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems' ability to provide population-wide access to essential medicines. Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products. This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.
Health System Efficiency
DOWNLOAD
FREE 30 Days
Author : Jonathan Cylus
language : en
Publisher: Health Policy
Release Date : 2016-12-15
Health System Efficiency written by Jonathan Cylus and has been published by Health Policy this book supported file pdf, txt, epub, kindle and other format this book has been release on 2016-12-15 with Medical categories.
In this book the authors explore the state of the art on efficiency measurement in health systems and international experts offer insights into the pitfalls and potential associated with various measurement techniques. The authors show that: - The core idea of efficiency is easy to understand in principle - maximizing valued outputs relative to inputs, but is often difficult to make operational in real-life situations - There have been numerous advances in data collection and availability, as well as innovative methodological approaches that give valuable insights into how efficiently health care is delivered - Our simple analytical framework can facilitate the development and interpretation of efficiency indicators.
Evaluation Of Health Services
DOWNLOAD
FREE 30 Days
Author : Sandeep Reddy
language : en
Publisher: BoD – Books on Demand
Release Date : 2020-03-11
Evaluation Of Health Services written by Sandeep Reddy and has been published by BoD – Books on Demand this book supported file pdf, txt, epub, kindle and other format this book has been release on 2020-03-11 with Medical categories.
As the costs and resources of delivering health services have increased over the years, the importance of evaluating health services and interventions has become essential. An evaluation provides a systematic process of assessing the efficacy and efficiency of health services, including an assessment of their impact on beneficiaries, whether it be individuals or communities. Evaluation in the health sector includes the evaluation of burden disease where human and economic costs resulting from poor health are measured.In this book, various evaluation studies are detailed, providing an excellent resource for both evaluation practitioners and academics alike. The geographical range and variety of case studies showcase how evaluation has become integral for health service planning and assessment and to assist public health policy makers decide how to use limited resources to minimize burden and inequity. This book will act as a ready resource for both workers experienced in health service evaluation and those intending to learn about burden of disease of evaluation.
Pharmacoeconomics
DOWNLOAD
FREE 30 Days
Author : Renee J. G. Arnold
language : en
Publisher: CRC Press
Release Date : 2016-04-19
Pharmacoeconomics written by Renee J. G. Arnold and has been published by CRC Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2016-04-19 with Medical categories.
The pharmaceutical industry is almost boundless in its ability to supply new drug therapies, but how does one decide which are the best medicines to use within restricted budgets? With particular emphasis on modeling, methodologies, data sources, and application to real-world dilemmas, Pharmacoeconomics: From Theory to Practice provides an introduc
Initial National Priorities For Comparative Effectiveness Research
DOWNLOAD
FREE 30 Days
Author : Institute of Medicine
language : en
Publisher: National Academies Press
Release Date : 2009-11-14
Initial National Priorities For Comparative Effectiveness Research written by Institute of Medicine and has been published by National Academies Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2009-11-14 with Medical categories.
Clinical research presents health care providers with information on the natural history and clinical presentations of disease as well as diagnostic and treatment options. In today's healthcare system, patients, physicians, clinicians and family caregivers often lack the sufficient scientific data and evidence they need to determine the best course of treatment for the patients' medical conditions. Initial National Priorities for Comparative Effectiveness Research(CER) is designed to fill this knowledge gap by assisting patients and healthcare providers across diverse settings in making more informed decisions. In this 2009 report, the Institute of Medicine's Committee on Comparative Effectiveness Research Prioritization establishes a working definition of CER, develops a priority list of research topics, and identifies the necessary requirements to support a robust and sustainable CER enterprise. As part of the 2009 American Recovery and Reinvestment Act, Congress appropriated $1.1 billion in federal support of CER, reflecting legislators' belief that better decisions about the use of health care could improve the public's health and reduce the cost of care. The Committee on Comparative Effectiveness Research Prioritization was successful in preparing a list 100 top priority CER topics and 10 recommendations for best practices in the field.